Phibro Animal Health Corp. Faces FDA Proposal to Withdraw Approval of Carbadox in Swine Feed

Summary

The FDA is proposing to withdraw approval of new animal drug applications for carbadox in medicated swine feed, giving Phibro Animal Health Corp. the opportunity to request a hearing on the proposal, citing a lack of approved detection methods for carcinogenic residues in edible swine tissues.